| abstract |
Provided is a method for discriminating, at a molecular level, between non-metastatic endometrial cancer and endometrial cancer possibly metastatic to the lymph nodes.　This method for assessing endometrial cancer metastasis to the lymph nodes or lymph node metastatic potential of endometrial cancer includes a step for measuring, in a biological sample derived from isolated cancer cells from an endometrial cancer patient, the level of expression of at least one expression product of DNA including a transcription start region, wherein said DNA comprises a base at any position in the transcription start region of a base sequence indicated by SEQ ID NO: 1-277 and at least one base continuing downstream therefrom, and said transcription start region is a region in which both ends thereof are specified by the first base of the base sequence indicated by SEQ ID NO: 1-277 and the 101th base from the 3' end. |